Nomenclature of the symptoms of head and neck cancer: a systematic scoping review
View/ Open
Odo_et_al_Frontiers_in_Oncology.pdf (1.312Mb)
Download
Publication date
2024-06Author
Bradley, P.T.Lee, Y.K.
Albutt, A.
Hardman, J.
Kellar, I.
Odo, Chinasa
Randell, Rebecca
Rousseau, N.
Tikka, T.
Patterson, J.M.
Paleri, V.
Rights
© 2024 Bradley, Lee, Albutt, Hardman, Kellar, Odo, Randell, Rousseau, Tikka, Patterson and Paleri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Peer-Reviewed
YesOpen Access status
openAccessAccepted for publication
2024-05-03
Metadata
Show full item recordAbstract
Introduction: Evolution of a patient-reported symptom-based risk stratification system to redesign the suspected head and neck cancer (HNC) referral pathway (EVEREST-HN) will use a broad and open approach to the nomenclature and symptomatology. It aims to capture and utilise the patient reported symptoms in a modern way to identify patients’ clinical problems more effectively and risk stratify the patient. Method: The review followed the PRISMA checklist for scoping reviews. A search strategy was carried out using Medline, Embase and Web of Science between January 1st 2012 and October 31st 2023. All titles, abstracts and full paper were screened for eligibility, papers were assessed for inclusion using predetermined criteria. Data was extracted pertaining to the aims, type of study, cancer type, numbers of patients included and symptoms, presenting complaints or signs and symptoms. Results: There were 9,331 publications identified in the searches, following title screening 350 abstracts were reviewed for inclusion and 120 were considered for eligibility for the review. 48 publications met the eligibility criteria and were included in the final review. Data from almost 11,000 HNC patients was included. Twenty-one of the publications were from the UK, most were retrospective examination of patient records. Data was extracted and charted according to the anatomical area of the head and neck where the symptoms are subjectively and objectively found, and presented according to lay terms for symptoms, clinical terms for symptoms and the language of objective clinical findings. Discussion: Symptoms of HNC are common presenting complaints, interpreting these along with clinical history, examination and risk factors will inform a clinician’s decision to refer as suspected cancer. UK Head and Neck specialists believe a different way of triaging the referrals is needed to assess the clinical risk of an undiagnosed HNC. EVEREST-HN aims to achieve this using the patient history of their symptoms. This review has highlighted issues in terms of what is considered a symptom, a presenting complaint and a clinical finding or sign.Version
Published versionCitation
Bradley PT, Lee YK, Albutt A et al (2024) Nomenclature of the symptoms of head and neck cancer: a systematic scoping review. Frontiers in Oncology. 14: 1404860.Link to Version of Record
https://doi.org/10.3389/fonc.2024.1404860Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.3389/fonc.2024.1404860